HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
C Astori Selected Research
C Astori Research Topics
Disease
2
Multiple Myeloma
12/2005 - 04/2001
2
Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2000 - 06/2000
1
Essential Thrombocythemia
02/2016
1
Primary Myelofibrosis (Myelosclerosis)
02/2016
1
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2002
1
Lymphoma (Lymphomas)
01/2002
1
Bone Diseases (Bone Disease)
04/2001
1
Bone Resorption
04/2001
1
Hodgkin Disease (Hodgkin's Disease)
10/2000
1
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
10/2000
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2000
1
Acute Myelomonocytic Leukemia
10/2000
1
Sepsis (Septicemia)
10/2000
1
Neoplasms (Cancer)
06/2000
1
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
06/2000
Drug/Important Bio-Agent (IBA)
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
12/2005 - 10/2000
2
Rituximab (Mabthera)
FDA Link
01/2002 - 06/2000
1
Calcium
IBA
02/2016
1
Calreticulin
IBA
02/2016
1
Dexamethasone (Maxidex)
FDA Link
Generic
12/2005
1
Cisplatin (Platino)
FDA Link
Generic
12/2005
1
Etoposide (VP 16)
FDA Link
Generic
12/2005
1
Osteocalcin
IBA
04/2001
1
Biomarkers (Surrogate Marker)
IBA
04/2001
1
Alkaline Phosphatase
IBA
04/2001
1
purine
IBA
10/2000
1
Alkylating Agents
IBA
10/2000
1
Chlorambucil (Leukeran)
FDA Link
10/2000
1
fludarabine
IBA
10/2000
1
Monoclonal Antibodies
IBA
06/2000
1
CD20 Antigens
IBA
06/2000
Therapy/Procedure
3
Drug Therapy (Chemotherapy)
01/2002 - 06/2000
3
Therapeutics
01/2002 - 06/2000
1
Hematopoietic Stem Cell Mobilization
12/2005
1
Immunotherapy
01/2002
1
Induction Chemotherapy
10/2000
1
Aftercare (After-Treatment)
10/2000
1
Combined Modality Therapy
10/2000
1
Laparotomy
10/2000
1
Adjuvant Radiotherapy
10/2000